Microsoft word - publicaciones cociente con if e hi

Publicaciones en las que COCIENTE S.L. ha participado en su redacción. Ordenadas por factor de impacto (2011) de la revista [Carta] Rico-Villademoros F, Calandre EP. Confounding by indication and the risk of hyperlipidemia in observational studies of antipsychotics. [Carta] Rico-Villademoros F, Calandre EP. Reasons for prescription of serotonin receptor 2A–blocking antidepressants may confound the association between their use and the occurrence of joint disorders: comment on the article by Kling et al. Arthritis Rheum 2010 May;62(5):744 Díaz-Marsá M, Sánchez S, Rico-Villademoros F. Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective prospective, and naturalistic study. J Clin Psychiatry 2009;70:509-17. Calandre EP, Rico-Villademoros F. The role of Saiz-Ruiz J, Ibáñez A, Díaz-Marsá M, Arias F, Carrasco JL, Huertas D, Martín-Carrasco M, Moreno I, Rico-Villademoros F. Nefazodone in the treatment of elderly patients with depressive observational study. CNS Drugs 2002;16:635-643. Montejo AL, Rico-Villademoros F; Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study. J Clin Psychopharmacol. 2008;28:568-70. [Carta] Rico-Villademoros F, Saiz-Ruiz J. Fluvoxamine in the Treatment of Late-Life Depression: How Much We Know Coming From Randomized Controlled Trials: Comment on Article by Dr Rossini and Colleagues. J Clin Psychopharmacol. 2007;27:98-99. Montejo Gonzalez AL, Rico-Villademoros F, Tafalla M, Majadas S; Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. observational study on the effects of quetiapine on sexual functioning. J Clin Psychopharmacol 2006;25:533-8. Pérez C, Navarro A, Saldaña MT, Martínez S, Rejas J. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia. 2009 Jul;29(7):781-90. Rico-Villademoros F, Calandre EP, Rodríguez- López CM, García-Carrillo J, Ballesteros J, Hidalgo-Tallón J, García-Leiva JM. Sexual Functioning in Women and Men with Fibromyalgia. J Sex Med. 2012 Feb;9(2):542-9. Montejo AL, Majadas S, Rico-Villademoros F, Llorca G, de la Gándara J, Franco M, Martín- Carrasco M, Aguera L, Prieto N; for the Spanish Working Group for the Study of Psychotropic-Related Frequency of Sexual Dysfunction in Patients with Hidalgo J, Rico-Villademoros F, Calandre EP. An open-label study of quetiapine in the treatment Rico-Villademoros F, Hidalgo J, Dominguez I, García-Leiva JM, Calandre EP. Atypical antipsychotics fibromyalgia: a case series with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:161-4. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study. Mol Genet Metab. 2011 Dec;104(4):480-4. Interpretation of Odds Ratios. Clin J Pain. Pérez C, Saldaña MT, Navarro A, Martínez S, Rejas J. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol. 2009 May;49(5):582-90. Calleja JL, García-Samaniego J, Ruiz-Antorán B, Trapero M, Morillas R, de la Revilla J, Erdozaín JC, Espinosa MD, Suárez D, Solá R, Romero-Gómez M, Baños F, Alvarez MA; for the Management of HCV Infection and Normal Transaminases Spanish Study Group. Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels. J Gastroenterol Hepatol. 2012 Nov;27(11):1705-1710. Bobes J, Rubio G, Terán A, Cervera G, López- Gómez V, Vilardaga I, Pérez M. Pregabalin for the benzodiazepines use: an assessment of its effectiveness in daily clinical practice. Eur Psychiatry. 2012 May;27(4):301-7. Rico-Villademoros F, Hernando T, Sanz JL, Lopez-Alonso A, Salamanca O, Camps C, Rosell R. The role of the clinical research coordinator--data clinical trials. BMC Med Res Methodol. 2004;4(1):6. Tafalla M, Salvador-Carulla L, Saiz-Ruiz J, Diez T, Cordero L. Pattern of healthcare resource utilization and direct costs associated with manic episodes in Spain. BMC Psychiatry. 2010 Apr 28;10:31. Rubio G, Bobes J, Cervera G, Terán A, Pérez M, López-Gómez V, Rejas J. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine Martinez-Trufero J, Alfaro J, Felipo F, Alvarez M, Madani J, Cebollero A. Response to trabectedin treatment in a highly pretreated patient hemangiopericytoma. Anticancer Drugs. 2010 Sep;21(8):795-8. Rico-Villademoros F, Hidalgo J, Morillas- Arques P, Vilchez JS, Delgado-Rodriguez A, Calandre EP. An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia management. Clin Exp Rheumatol. 2009;27(5 Suppl 56):S16-20 Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Compr Psychiatry. 2012 Feb;53(2):145-51. Calleja JL, Bixquert M, Maldonado J; for the SINERGE Study Group. Impact of nocturnal heartburn on quality of life, sleep, and productivity: the SINERGE study. Dig Dis Sci. 2007 Oct;52(10):2858-65. Guardia J, Roncero C, Galan J, Gonzalvo B, Burguete T, Casas M. A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients. Addict Behav. 2011 Mar;36(3):265-9. Rico-Villademoros F, Rodriguez-Lopez CM, Morillas-Arques P, Vilchez JS, Hidalgo J, Calandre EP. Amisulpride in the treatment of fibromyalgia: an uncontrolled study. Clin Rheumatol. 2012 Sep;31(9):1371-5 Saldaña MT, Navarro A, Pérez C, Masramón X, subjects with painful lumbar or cervical radiculopathy evidence from medical practice in primary care Rodríguez-Andreu J, Ibáñez-Bosch R, Portero- Vázquez A, Masramon X, Rejas J, Gálvez R. Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental Musculoskelet Disord. 2009 Dec 21;10:162. Llorente A, Perez-Valero I, García E, Heras I, Fraile V, García P, López J, Salavert M, Bobillo F. Mortality risk factors in patients with zygomycosis: a retrospective and multicentre study of 25 cases. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):263-8. García Del Muro X, Martín J, Maurel J, Cubedo R, Bagué S, de Álava E, Pousa AL, Narváez JA, Ortiz E, Pomés J, Poveda A, Romasanta LP, Tendero O, Viñals JM; Grupo Español de Investigación en Sarcomas (GEIS). Guía de práctica clínica en los sarcomas de partes blandas. 9;136(9):408.e1-8. [Edición del artículo] Montenegro J, Cornago I, Gallardo I, García- Ledesma P, Hernando A, Martinez I, Muñoz RI, Romero MA. Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism advanced chronic kidney disease before initiation of regular dialysis. Nephrology (Carlton). 2012 Jan;17(1):26-31. Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) schizophrenia and other psychotic disorders. J Sex Marital Ther. 2008;34:227-39. Tafalla M, Nuevo J, Zapardiel J, Gisbert JP. [Study of the clinical profile and management of patients with gastroesophageal reflux disease Nuevo J, Tafalla M, Zapardiel J, Gisbert JP. [Use of health resources and loss of productivity disease: results of a cross-sectional study in a primary care setting in Spain]. Aten Primaria. 2011 Sep;43(9):474-81. Gibert J, Giner J, Bobes J, Tafalla M, Herranz S, Ovejero C, Rico-Villademoros F, for the SOS Group. The ‘Seroquel’ Outcomes Study (SOS): efficacy and tolerability of quetiapine in a long-term, naturalistic study of patients with schizophrenia. Int J Psychiatry Clin Pract 2007;11:222-232. Gibert J, Giner J, Bobes J, Tafalla M, Herranz S, Ovejero C, Rico-Villademoros F; for the SOS GROUP. The "Seroquel" Outcomes Study (SOS): Efficacy and tolerability oí quetiapine in a long-term, naturalistic study oí patients with schizophrenia. Psychiatry in Clinical Practice 2007;11(3):222-232. Sociedad Española de Psiquiatría y Sociedad Española de Psiquiatría Biológica. Rev Psiquiatr Salud Ment (Barc.). 2011;4:150-168 Bobes J, Saiz J, Montes JM, Mostaza J, Rico- Villademoros F, Vieta E. Consenso español sobre salud física del paciente con trastorno bipolar. Rev Psiquiatr Salud Ment (Barc) 2008;1:26-37. Calandre EP, Rico-Villademoros F, Rodríguez- López CM. Monotherapy or Combination Therapy for Fibromyalgia Treatment? Curr Rheumatol Rep. 2012 Jul 18. [Epub ahead of print] PMID: 22806139 Neyro Bilbao JL, Palacios Gil-Antuñano S, Cano Sánchez A. Perfil de acción de denosumab en el tratamiento de la osteoporosis. Rev Osteoporos Metab Miner 2011 3;4:183-188 Neyro Bilbao JL, Cano Sánchez A, Palacios Gil- Antuñano S. Regulación del metabolismo óseo a través del sistema RANK-RANKL-OPG. Rev Osteoporos Metab Miner 2011 3;2:105-112 Pérez C, Margarit C, Gálvez R. A Review of Pregabalin for the Treatment of Peripheral and Central Neuropathic Pain and Its Place in the Treatment of Chronic Pain. Clinical Medicine Reviews in Therapeutics 2011:3 325–346

Source: http://cociente.es/docs/PUBLICACIONES%20COCIENTE%20S.L..pdf

Untitled

Two Major Outcome Studies Demonstrate The Clinical Significance of Central Blood Pressures Two major cardiovascular outcomes trials presented at American Heart Association Scientific Sessions 2005 – the Conduit Artery Functional Endpoint (CAFE)1study and a NIH-sponsored Strong Heart sub-study2 – establish the importance of central blood pressures in assessing cardiovascular risk an

Copyright © 2010-2019 Pdf Physician Treatment